Trial · NCT03282799
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Amenorrhea | Reproductive system and breast disorders | Standard Dose Etonogestrel Implant | 2 | 36 | 2 |
| other | Amenorrhea | Reproductive system and breast disorders | Increased Dose Etonogestrel Implant | 3 | 36 | 3 |
| other | Menorrhagia | Reproductive system and breast disorders | Standard Dose Etonogestrel Implant | 23 | 36 | 40 |
| other | Menorrhagia | Reproductive system and breast disorders | Increased Dose Etonogestrel Implant | 30 | 36 | 68 |
| other | Metrorrhagia | Reproductive system and breast disorders | Standard Dose Etonogestrel Implant | 14 | 36 | 20 |
| other | Metrorrhagia | Reproductive system and breast disorders | Increased Dose Etonogestrel Implant | 22 | 36 | 33 |
| other | Dysmenorrhea | Reproductive system and breast disorders | Standard Dose Etonogestrel Implant | 8 | 36 | 10 |
| other | Dysmenorrhea | Reproductive system and breast disorders | Increased Dose Etonogestrel Implant | 10 | 36 | 12 |
| other | Weight Gain | General disorders | Standard Dose Etonogestrel Implant | 1 | 36 | 1 |
| other | Weight Gain | General disorders | Increased Dose Etonogestrel Implant | 3 | 36 | 3 |
| other | Headache | Nervous system disorders | Standard Dose Etonogestrel Implant | 16 | 36 | 26 |
| other | Headache | Nervous system disorders | Increased Dose Etonogestrel Implant | 15 | 36 | 23 |
| other | Breast Tenderness | Reproductive system and breast disorders | Standard Dose Etonogestrel Implant | 1 | 36 | 2 |
| other | Breast Tenderness | Reproductive system and breast disorders | Increased Dose Etonogestrel Implant | 4 | 36 | 5 |
| other | Nausea | Gastrointestinal disorders | Standard Dose Etonogestrel Implant | 4 | 36 | 5 |
| other | Nausea | Gastrointestinal disorders | Increased Dose Etonogestrel Implant | 4 | 36 | 4 |
| other | Acne | Skin and subcutaneous tissue disorders | Standard Dose Etonogestrel Implant | 9 | 36 | 9 |
| other | Acne | Skin and subcutaneous tissue disorders | Increased Dose Etonogestrel Implant | 6 | 36 | 6 |
| other | Implant Site Reaction | Product Issues | Standard Dose Etonogestrel Implant | 15 | 36 | 19 |
| other | Implant Site Reaction | Product Issues | Increased Dose Etonogestrel Implant | 24 | 36 | 29 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03282799/events